Summary of Purpose
This is a randomized, double blind, placebo-controlled, parallel, multicenter research in order to evaluate the effect of Shuxuetong injection in prevention of symptomatic or asymptomatic new cerebral infarction within 10 days. Subgroup study：Evaluate the role of advanced diagnostic technique in identifying potential causes of Embolic Stroke of Undetermined Source (ESUS).Read More →
The following dates are available for this trial. Trial information last updated on 20 November 2017.
|12 May 2017||9 Mar 2017||1 Dec 2018||1 Dec 2018||1 Nov 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|